Charles Mesguich

9PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 16, 2024
Course of immune thrombocytopenia according to the site of platelet destruction identified by indium-111 platelet scintigraphy.

Pauline Durand, Valérie Pottier, Frédéric Debordeaux

|Apr 30, 2021
Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant.

Charles Mesguich, Valérie Latrabe, Cyrille Hulin

|Sep 20, 2020
Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.

Charles Mesguich, Cyrille Hulin, Valerie Latrabe

|Sep 10, 2020
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.

Charles Mesguich, Cyrille Hulin, Valerie Latrabe

|Jun 03, 2020
Choline PET/CT in Multiple Myeloma.

Charles Mesguich, Cyrille Hulin, Axelle Lascaux

|Aug 08, 2019
Prognostic utility of pre-transplantation [18 F] fluorodeoxyglucose positron emission tomography/computed tomography in patients with diffuse large B-cell lymphoma who underwent rituximab, dexamethasone, high-dose cytarabine, carboplatin salvage chemotherapy.

Charles Mesguich, Alexandre Roch, Elif Hindié

Pageof 2

Frequent Collaborators

1 joint publications

Cyrille Hulin

1 joint publications

Valerie Latrabe

1 joint publications

Julien Asselineau

1 joint publications

Laurence Bordenave